Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05846789 |
| Title | Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Kathy Miller |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| IU Health Joe and Shelly Schwarz Cancer Center | RECRUITING | Carmel | Indiana | 46032 | United States | Details |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | RECRUITING | Indianapolis | Indiana | 46202 | United States | Details |
| Sidney and Lois Eskenazi Hospital | RECRUITING | Indianapolis | Indiana | 46202 | United States | Details |
| Roswell Park Comprehensive Cancer Center | RECRUITING | Buffalo | New York | 14203 | United States | Details |